Mast Therapeutics Inc (NYSE MKT LLC:MSTX)
| 0.73 Data as of May 24 |  +0.04 / +5.80%Today’s Change | 0.45 Today|||52-Week Range 0.92 | +28.07% Year-to-Date |
Latest MSTX News | Press Releases
No recent news for Mast Therapeutics Inc.
Today’s Trading
| Previous close | 0.69 |
| Today’s open | 0.67 |
| Day’s range | 0.66 - 0.74 |
| Volume | 614,021 |
| Average volume (3 months) | 237,223 |
| Market cap | $33.8M |
| Dividend yield | -- |
Data as of 3:59pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +29.79% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +57.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| HEBHemispherx Biopharma... | -0.00 | -0.25% |
| ECTEEcho Therapeutics In... | +0.03 | +5.45% |
| IPCIIntellipharmaceutics... | +0.03 | +1.72% |
| BLRXBioline RX Ltd | -0.05 | -2.98% |
Data as of 3:59pm ET, 05/24/2013
Financials
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$15.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Brian M. Culley, MBA, CPA |
President, Chief Operating Officer & Secretary Patrick L. Keran |
Corporate headquarters San Diego, California |
Forecasts
